Logo image of CRHM

CRH Medical Corp (CRHM) Stock Overview

USA - NYSEARCA:CRHM -

3.99
0 (0%)
Last: 4/22/2021, 8:04:02 PM

CRHM Key Statistics, Chart & Performance

Key Statistics
Market Cap285.76M
Revenue(TTM)106.17M
Net Income(TTM)-24476100
Shares71.62M
Float49.21M
52 Week High4.01
52 Week Low1.66
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.04
PEN/A
Fwd PE399
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


CRHM short term performance overview.The bars show the price performance of CRHM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80

CRHM long term performance overview.The bars show the price performance of CRHM in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of CRHM is 3.99 null. In the past month the price increased by 1.53%. In the past year, price increased by 102.54%.

CRH Medical Corp / CRHM Daily stock chart

CRHM Latest News, Press Relases and Analysis

About CRHM

Company Profile

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.

Company Info

CRH Medical Corp

619 - 999 CANADA PLACE WORLD TRADE CENTER

VANCOUVER A1 V6C 3E1

CEO: Tushar Ramani

Phone: 604-633-1440

CRH Medical Corp / CRHM FAQ

What does CRHM do?

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.


Can you provide the latest stock price for CRH Medical Corp?

The current stock price of CRHM is 3.99 null.


Does CRH Medical Corp pay dividends?

CRHM does not pay a dividend.


How is the ChartMill rating for CRH Medical Corp?

CRHM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the ownership structure of CRH Medical Corp (CRHM)?

You can find the ownership structure of CRH Medical Corp (CRHM) on the Ownership tab.


CRHM Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to CRHM. When comparing the yearly performance of all stocks, CRHM is one of the better performing stocks in the market, outperforming 87.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CRHM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CRHM. CRHM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRHM Financial Highlights

Over the last trailing twelve months CRHM reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -180% compared to the year before.


Industry RankSector Rank
PM (TTM) -23.05%
ROA -12.76%
ROE N/A
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%21.12%
EPS 1Y (TTM)-180%
Revenue 1Y (TTM)-11.81%

CRHM Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y125%
Revenue Next YearN/A

CRHM Ownership

Ownership
Inst Owners0.02%
Ins Owners0.81%
Short Float %N/A
Short RatioN/A